01 Introduction to Biotechnology
Learn what biotechnology includes, how it developed, where it is applied, and how ethical, safety, and regulatory considerations shape its responsible use.
What includes
uses living organisms, cells, or biological molecules to create products, improve processes, or solve problems. It is a broad field, not a single technique, and combines biology with chemistry, engineering, computing, and other disciplines.
Its methods range from traditional practices to techniques that work directly with cells, genes, proteins, and biological data. Yeast used to make bread and genetically engineered cells used to produce a medicine are both examples: each relies on a biological system to achieve a useful result.
From traditional practice to modern
People practiced long before they understood cells or DNA. , domestication, and selective breeding helped produce foods, crops, and animals with useful characteristics. Modern developed as scientific knowledge made it possible to study and manipulate biological systems more directly.
Important milestones include:
Ancient and premodern eras: and selective breeding applied biological processes in food production and agriculture.
1953: The double-helix model of DNA helped establish a foundation for understanding how genetic information is stored.
Early 1970s: Researchers produced by joining DNA fragments and introducing them into host cells.
Late 1970s onward: Recombinant methods supported the production of human proteins in microorganisms and the growth of companies.
Recent decades: Genome sequencing, , and genome-editing tools expanded the ability to study and alter biological systems.
These milestones mark changes in scientific understanding and capability; did not begin only with modern genetics.
Branches and applications
is often grouped by the problems it addresses. These categories help organize examples, but they are not rigid or universally standardized divisions.
Medical develops or improves diagnostics, medicines, vaccines, and other health technologies. Engineered cells can, for example, produce a therapeutic protein.
Agricultural applies biological tools to crops, livestock, and food production. Goals may include improving useful traits or protecting plants from pests and disease.
Industrial uses organisms, cells, or enzymes in manufacturing. Biological catalysts can help make chemicals, materials, or fuels.
Environmental applies biological processes to environmental monitoring and management, including the treatment of some wastes or contaminants.
Computational uses and related tools to store, compare, and interpret biological data, such as DNA sequences.
The branches overlap. Producing a medicine with engineered cells can involve genetic research, cell culture, data analysis, manufacturing, quality control, and safety review. The application areas and the methods used to pursue them are related but distinct ways of describing .
Ethics and social consequences
can bring substantial benefits, but decisions about its use also involve values and social consequences. Ethical review considers not only whether a method works, but also who may benefit, who may bear risks, and whether affected people have a meaningful say.
Important considerations include:
Consent and privacy: People should understand how their biological samples or genetic information may be used and protected.
Fairness and access: Benefits should not be limited to groups that already have greater resources while risks fall disproportionately on others.
Human dignity and rights: Genetic characteristics should not be used to reduce a person to a biological profile or justify discrimination. Considerations include dignity, rights, prior risk–benefit assessment, and .
Animal welfare and environmental effects: Research and applications should consider impacts on animals, ecosystems, and biodiversity.
Responsible innovation: Some knowledge or technologies could be misused or have consequences beyond their intended purpose. Oversight, transparency, and public engagement can help address these concerns.
Changing a person’s cells to treat a disease raises questions about safety, consent, and access. Editing changes that could be inherited by future generations raises additional concerns because people who may be affected cannot consent themselves. Ethical analysis should be proportionate to the technology and its possible consequences.
Safety and responsible research
laboratories manage biological, chemical, physical, and equipment-related hazards. focuses on preventing accidental exposure to or release of biological material. focuses on preventing loss, theft, unauthorized access, or misuse. Both depend on suitable procedures, training, oversight, and a culture in which incidents and concerns are reported.
A central safety practice is : identify hazards, consider how likely exposure or harm is and how serious its consequences could be, then choose controls suited to the work. Controls may include safe work practices, appropriate protective equipment, containment, training, and waste management. A risk- and evidence-based approach avoids assuming that every activity requires identical precautions.
Research intended for beneficial purposes may raise concerns if it could potentially be misapplied. Responsible oversight aims to reduce those risks while enabling legitimate research.
Regulation depends on product and use
rules differ across countries and depend on the product, its intended use, and the risks it may present. Regulation can address human and animal health, food safety, environmental protection, medicines, and workplace or laboratory safety. Ethical review and institutional oversight may apply alongside legal requirements.
In the United States, oversight is shared among federal agencies. The describes the roles of the Food and Drug Administration (FDA), Environmental Protection Agency (EPA), and Department of Agriculture (USDA), which apply their existing legal authorities to different products and uses. The applicable pathway is therefore not identical for every product.
The agencies’ 2024 joint plan described work to clarify and coordinate oversight for areas including modified plants, animals, and microorganisms, as well as human drugs, biologics, and medical devices. Researchers and developers must determine which requirements apply to their specific work; a general overview cannot substitute for current agency guidance.